Health Care & Hospital Law
Mar. 27, 2010
Hidden Prize for Biotech
When President Barack Obama signed the landmark health care overhaul into law this week, he also handed over 30 million new paying customers to drug companies, boosting their stock prices.
Daily Journal Staff Writer
When President Barack Obama signed the landmark health care overhaul into law this week, he also handed over 30 million new paying customers to drug companies, boosting their stock prices.
But the new reform law gave the biotech sector an even bigger win: a $1 billion tax break and a 12-year exclusivity period on infusion and injection-type drugs, called "biologics" th...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In